biguanides has been researched along with Experimental Leukemia in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosowsky, A | 1 |
| Chen, KK | 1 |
| Amand, RS | 1 |
| Modest, EJ | 1 |
1 other study available for biguanides and Experimental Leukemia
| Article | Year |
|---|---|
Chemical and biological studies on 1,2-dihydro-s-triazines. 18. Synthesis of 1-(5,6- and 5,7-dichloro-2-naphthyl) derivatives and related compounds as candidate antimalarial and antitumor agents.
Topics: Animals; Antimalarials; Antineoplastic Agents; Ascites; Biguanides; Carcinoma, Squamous Cell; Cells; | 1973 |